Monitored implementation of P.L. 117-169, the Inflation Reduction Act as it relates to drug pricing. Issues related to biosimilars. Monitored issues related to cardiovascular health. Issues related to pharmacy benefit management. Monitored issues related to dialysis services. H.R. 1, One Big Beautiful Bill Act, as it relates to pharmacy benefit management and drug pricing policies. H.R. 946 / S. 1862, ORPHAN Cures Act. Issues related to the Most Favored Nation drug pricing.
Issues related to pharmacy benefit management. Issues related to cardiovascular care. Issues related to drug pricing.
Monitored issues related to intellectual property.
H.R. 1990, the American Innovation and R&D Competitiveness Act, as it relates to the R&D tax credit. Issues related to the extension of the 2017 Tax Cut and Jobs Act, and corporate taxes. H.R. 1, One Big Beautiful Bill Act, as it relates to corporate taxes.